Málek P, Kolc J, Rossmann P, Ruźbarský V, Ratuský J
Czech Med. 1978;1(2):99-103.
Mercurascan (MSC), a mercury derivative of fluorescein, was studied as to its effect on the survival of allogeneic kidney grafts in dogs. A single perfusion of the donor's kidney with saline solution with MSC added in a ratio of 1 mg/100 ml was found to have significantly extended the graft survival time from 10.8 days (SE +/- 0.6) to 15.4 days (SE +/- 1.6). Graft survival time extension proved to be even more significant after a single dose of MSC given to the donor (0.5 mg/kg b.w.) and repeated administration of an equal MSC dose to the recipient twice weekly. Listed are detailed morphological changes in tissue specimens from the kidney, lymph nodes, spleen, and many other organs of a dog surviving for 42 days. A very moderate rejection lesion with merely tiny lymphocytic infiltrates was proved in the kidney. Lymph node structure was almost entirely obliterated with lymphoid tissue extinction. There was loss of white pulp in the spleen. The absence of morphological changes in the other organs suggested good tolerance of the preparation. More studies are called for to elucidate the complex MSC intervention in the process of rejection.
对荧光素汞衍生物Mercurascan(MSC)在犬同种异体肾移植存活方面的作用进行了研究。发现用添加了MSC(比例为1毫克/100毫升)的盐溶液对供体肾脏进行单次灌注,可使移植存活时间从10.8天(标准误±0.6)显著延长至15.4天(标准误±1.6)。在给供体单次注射MSC(0.5毫克/千克体重)并每周给受体重复注射同等剂量的MSC两次后,移植存活时间的延长更为显著。列出了一只存活42天的犬的肾脏、淋巴结、脾脏和许多其他器官的组织标本中的详细形态学变化。在肾脏中证实存在非常轻微的排斥病变,仅有微小的淋巴细胞浸润。淋巴结结构几乎完全被破坏,淋巴组织消失。脾脏中白髓减少。其他器官无形态学变化表明该制剂耐受性良好。需要进行更多研究以阐明MSC在排斥过程中的复杂干预作用。